 |
|
|
| |
Outcomes 48 weeks after switching from DTG/ABC/3TC or DTG+F/TAF to B/F/TAF
|
| |
| |
18th European AIDS Conference (EACS), October 27-30, 2021, Virtual & London, United Kingdom
A. Pozniak1, F. Maggiolo2, D. Podzamczer3, Y. Yazdanpanah4, S. Gupta5, S. Esser6, K. Mounzer7, R. Grossberg8, F. Post9, H. Huang10, R. Acosta10, J. Baeten10, J. Hindman10, H. Martin10, C. Orkin11
1Chelsea and Westminster Hospital, London, United Kingdom, 2Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy, 3Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain, 4AP-HP Hôpital Bichat, Paris, France, 5Indiana University, Indianapolis, United States, 6University Hospital Essen, Essen, Germany, 7Philadelphia FIGHT/Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, United States, 8Albert Einstein College of Medicine, Bronx, United States, 9King's College Hospital NHS Foundation Trust, King's College Hospital, London, United Kingdom, 10Gilead Sciences Inc., Foster City, United States, 11Queen Mary University of London, London, United Kingdom
|
| |
|
|
|
|
|
